Genomic Vision: Postponement of the ordinary general meeting of shareholders of June 28, 2022

BAGNEUX, France, June 27, 2022–(BUSINESSWIRE)–Regulatory News: Genomic Vision (FR0011799907 – GV, PEA-PME eligible – the “Company”) (Paris:GV)a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications, informs its shareholders that, in view of the requests for admission cards, postal voting forms and proxies received at today by the … Read more

Podcast Hashtag Trends, June 2, 2022 — The exascale era, more dynamic meetings, Twitter shareholders against Musk and more | IT Department – News

Podcast Hashtag Trends June 2 2022 — The exascale era

Podcast Hashtag Trends, June 2, 2022 — Computing enters the exascale era, Microsoft wants to make meetings more dynamic, Twitter shareholders against Musk and the artificial intelligence that creates images. Welcome to Hashtag Trends, your roundup of tech news this week. Today is Thursday, June 2, 2022. Computing enters the exascale era The Frontier supercomputer … Read more

Genomic Vision: Availability of preparatory documents and procedures for participation and voting at the extraordinary general meeting of shareholders of May 23, 2022

BAGNEUX, France, May 02, 2022–(BUSINESSWIRE)–Regulatory News: Genomic Vision (FR0011799907 – GV, PEA-PME eligible) (Paris:GV)a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications, announces today the availability of the preparatory documents for its extraordinary general meeting to be held on May 23, 2022 at 2 p.m. company headquarters. … Read more